NIMBEX Side Effects

6969040-2 | Cardiac Arrest
on Sep 07, 2010 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with sickle cell anaemia with crisis, pain (What is pain?), mechanical ventilation, aggression, prophylaxis, hypotension and was treated with Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Nimbex dosage: Per Kg Pt Wt 60 Kg 1.2 Mg/0.6cc. During the same period patient was treated with BENADRYL (Ivp As Needed) (View Benadryl Review and Benadryl Label ), DEMEROL (W/phenergan 50/25 Ivp As Needed) (View Demerol Review and Demerol Label ), PROPOFOL (Continuous Drip Sedation) (View Propofol Review and Propofol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), HALOPERIDOL (Ivp Q 4 As Needed) (View Haloperidol Review and Haloperidol Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LEVOPHED BITARTRAT (Titrated Continuous Drip) (View Levophed Bitartrat Review and Levophed Bitartrat Label ).

6964922-X | Cardiac Arrest
Patient was taking Nimbex (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with sickle cell anaemia with crisis, pain (What is pain?), mechanical ventilation, aggression, prophylaxis, hypotension, breakthrough pain and. Nimbex dosage: Per Kg Pt Wt 60 Kg 1.2 Mg/0.6cc. During the same period patient was treated with BENADRYL (Ivp As Needed) (View Benadryl Review and Benadryl Label ), DEMEROL (W/phenergan 50/25 Ivp As Needed) (View Demerol Review and Demerol Label ), PROPOFOL (Continuous Drip Sedation) (View Propofol Review and Propofol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), HALOPERIDOL (Ivp Q 4 As Needed) (View Haloperidol Review and Haloperidol Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LEVOPHED BITARTRAT (Titrated Continuous Drip) (View Levophed Bitartrat Review and Levophed Bitartrat Label ), MORPHINE (Q1hr As Required Ivp) (View Morphine Review and Morphine Label ).

6708680-2 | Cardiac Disorder, Circulatory Collapse, Diaphragmatic Disorder, Electromechanical Dissociation, Pericardial Effusion
Adverse event was reported on Apr 23, 2010 by a Male patient taking Nimbex (View Usage) (Dosage: 10 Mg With Another 20 Mg Given Later) was diagnosed with anaesthesia procedure and. Location: UNITED STATES , weighting 176.4 lb, After Nimbex was administered, patient had the following side effects: cardiac disorder, circulatory collapse, diaphragmatic disorder, electromechanical dissociation, pericardial effusion. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

6431357-8 | Ascites, Congenital Genitourinary Abnormality, Premature Baby, Urinary Bladder Rupture
on Oct 29, 2009 Female patient from UNITED STATES , weighting 3.31 lb, was treated with Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, congenital genitourinary abnormality, premature baby, urinary bladder rupture. Nimbex dosage: .


6335035-5 | Cardiac Arrest
on Aug 21, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with anaesthesia and was treated with Nimbex (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Nimbex dosage: . During the same period patient was treated with ETOMIDATE (View Etomidate Review and Etomidate Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), HEPARIN (View Heparin Review and Heparin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ROBINUL (View Robinul Review and Robinul Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ).

6059042-5 | Anaphylactic Shock, Angioedema, Rash
Patient was taking Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: anaphylactic shock, angioedema, rash (What is rash?) on Jan 19, 2009 from FRANCE Additional patient health information: Female patient , 32 years of age, . Nimbex dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

6054480-9 | Hyperthermia Malignant
Adverse event was reported on Jan 21, 2009 by a Female patient taking Nimbex (View Usage) (Dosage: ) was diagnosed with neuromuscular blockade and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: hyperthermia malignant.

5946520-X | Blood Pressure Systolic Decreased, Erythema, Hypersensitivity, Tachycardia
on Oct 29, 2008 Male patient from FRANCE , 56 years of age, was diagnosed with prophylaxis and was treated with Nimbex (View Usage). Patient had the following side effects: blood pressure systolic decreased, erythema, hypersensitivity, tachycardia. Nimbex dosage: . During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), PROPOFOL (View Propofol Review and Propofol Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), GELOFUSINE (View Gelofusine Review and Gelofusine Label ).

5566865-5 | Mydriasis, Pupil Fixed
on Jan 18, 2007 Female patient from UNITED STATES , weighting 149.1 lb, was diagnosed with heart valve replacement and was treated with Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: mydriasis, pupil fixed. Nimbex dosage: 40 Mg In 100 Ml Ns @ 13 Cc/hr; Iv-drip.

5398594-5 | Dermatitis Bullous, Hypotension, Rash Erythematous, Skin Exfoliation, Stevens-johnson Syndrome
Patient was taking Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, hypotension, rash erythematous, skin exfoliation, stevens-johnson syndrome on Jul 20, 2007 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with anaesthesia, analgesia, thrombosis prophylaxis, pain (What is pain?) and. Nimbex dosage: . During the same period patient was treated with ORUDIS (View Orudis Review and Orudis Label ), HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TRIMEBUTINE MALEATE (View Trimebutine Maleate Review and Trimebutine Maleate Label ), REMIFENTANIL HYDROCHLORIDE (View Remifentanil Hydrochloride Review and Remifentanil Hydrochloride Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5351882-0 | Blood Pressure Decreased, Unwanted Awareness During Anaesthesia
Adverse event was reported on Jun 05, 2007 by a Female patient taking Nimbex (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: POLAND , 51 years of age, weighting 152.1 lb, Patient had the following side effects: blood pressure decreased, unwanted awareness during anaesthesia. During the same period patient was treated with ISOFLURANE (View Isoflurane Review and Isoflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

5308017-X | Anaphylactic Reaction, Flushing
on Aug 18, 2006 Female patient from UNITED STATES , 47 years of age, was diagnosed with induction of anaesthesia and was treated with Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: anaphylactic reaction, flushing. Nimbex dosage: Intravenous. During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5205936-X | Anaphylactic Shock, Hypotension
on Jan 08, 2007 Female patient from FRANCE , 85 years of age, was treated with Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, hypotension. Nimbex dosage: . During the same period patient was treated with CELOCURINE (50mg Per Day) (View Celocurine Review and Celocurine Label ), HYPNOMIDATE (View Hypnomidate Review and Hypnomidate Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), CEFAZOLIN SODIUM (2g Per Day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ).

5205828-6 | Convulsion, Incorrect Dose Administered, Tremor
Patient was taking Nimbex (View Usage). Patient had the following side effects: convulsion, incorrect dose administered, tremor on Jan 05, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 136.9 lb, was diagnosed with paralysis (What is paralysis?) and. Nimbex dosage: 10 Mg Once Iv Bolus.

5076977-0 | Anaphylactic Shock, Hypotension
Adverse event was reported on Jul 31, 2006 by a Female patient taking Nimbex (View Usage) (Dosage: ) . Location: FRANCE , 85 years of age, After Nimbex was administered, patient had the following side effects: anaphylactic shock, hypotension. During the same period patient was treated with CELOCURINE (50mg Per Day) (View Celocurine Review and Celocurine Label ), HYPNOMIDATE (View Hypnomidate Review and Hypnomidate Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), CEFAZOLIN SODIUM (2g Per Day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ).

5066708-2 | Anaphylactic Shock, Hypotension
on Jul 31, 2006 Female patient from FRANCE , 85 years of age, was treated with Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, hypotension. Nimbex dosage: . During the same period patient was treated with CELOCURINE (50mg Per Day) (View Celocurine Review and Celocurine Label ), HYPNOMIDATE (View Hypnomidate Review and Hypnomidate Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CEFAZOLIN SODIUM (2g Per Day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ).

5017630-9 | Loss Of Consciousness, Mydriasis, Unresponsive To Pain Stimuli
on May 24, 2006 Female patient from UNITED STATES , 20 years of age, was diagnosed with convulsion and was treated with Nimbex (View Usage). Patient had the following side effects: loss of consciousness, mydriasis, unresponsive to pain stimuli. Nimbex dosage: .

4945951-4 | Anaphylactic Reaction
Patient was taking Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: anaphylactic reaction on Sep 20, 2005 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 202.8 lb, was diagnosed with anaesthesia and. Nimbex dosage: Intravenous.

4945950-2 | Neuromuscular Block Prolonged
Adverse event was reported on Apr 18, 2005 by a Male patient taking Nimbex (View Usage) (Dosage: 0.2 Mg/kg, Intravenous) . Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged.

4898828-7 | Oedema, Urticaria
on Nov 22, 2005 Male patient from FRANCE , 52 years of age, was diagnosed with antibiotic prophylaxis, nerve block and was treated with Nimbex (View Usage). Patient had the following side effects: oedema, urticaria. Nimbex dosage: . During the same period patient was treated with CEFACIDAL (View Cefacidal Review and Cefacidal Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ), TRASYLOL (View Trasylol Review and Trasylol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CATAPRES (View Catapres Review and Catapres Label ). Patient was hospitalized.

4891188-7 | Oedema, Urticaria
on Nov 22, 2005 Male patient from FRANCE , 52 years of age, was diagnosed with antibiotic prophylaxis, nerve block and was treated with Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: oedema, urticaria. Nimbex dosage: . During the same period patient was treated with CEFACIDAL (View Cefacidal Review and Cefacidal Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ), TRASYLOL (View Trasylol Review and Trasylol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CATAPRES (View Catapres Review and Catapres Label ). Patient was hospitalized.

4871795-8 | Anaphylactoid Reaction, Angioneurotic Oedema, Hypersensitivity, Hypotension, Tachycardia
Patient was taking Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, angioneurotic oedema, hypersensitivity, hypotension, tachycardia on Apr 07, 2005 from FRANCE Additional patient health information: Female patient , 46 years of age, weighting 114.6 lb, was diagnosed with antibiotic prophylaxis and. Nimbex dosage: 10mg Per Day. During the same period patient was treated with AUGMENTIN '125' (2g Per Day) (View Augmentin '125' Review and Augmentin '125' Label ), CELOCURINE (60mg Per Day) (View Celocurine Review and Celocurine Label ), PERFALGAN (1g Per Day) (View Perfalgan Review and Perfalgan Label ), PROPOFOL (200mg Per Day) (View Propofol Review and Propofol Label ), GELOFUSINE (200ml Per Day) (View Gelofusine Review and Gelofusine Label ), SUFENTA (35mcg Per Day) (View Sufenta Review and Sufenta Label ), BETADINE (View Betadine Review and Betadine Label ).

4839115-2 | Oedema, Urticaria
Adverse event was reported on Nov 22, 2005 by a Male patient taking Nimbex (View Usage) (Dosage: ) was diagnosed with antibiotic prophylaxis and. Location: FRANCE , 52 years of age, Patient had the following side effects: oedema, urticaria. During the same period patient was treated with CEFACIDAL (View Cefacidal Review and Cefacidal Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ), TRASYLOL (View Trasylol Review and Trasylol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ). Patient was hospitalized.

4837485-2 | Anaphylactoid Reaction, Angioneurotic Oedema, Hypersensitivity, Hypotension, Tachycardia
on Apr 07, 2005 Female patient from FRANCE , 46 years of age, weighting 114.6 lb, was diagnosed with antibiotic prophylaxis and was treated with Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: anaphylactoid reaction, angioneurotic oedema, hypersensitivity, hypotension, tachycardia. Nimbex dosage: 10mg Per Day. During the same period patient was treated with AUGMENTIN '125' (2g Per Day) (View Augmentin '125' Review and Augmentin '125' Label ), CELOCURINE (60mg Per Day) (View Celocurine Review and Celocurine Label ), PERFALGAN (1g Per Day) (View Perfalgan Review and Perfalgan Label ), PROPOFOL (200mg Per Day) (View Propofol Review and Propofol Label ), GELOFUSINE (200ml Per Day) (View Gelofusine Review and Gelofusine Label ), SUFENTA (35mcg Per Day) (View Sufenta Review and Sufenta Label ), BETADINE (View Betadine Review and Betadine Label ).

4777005-4 | Anaphylactic Shock, Angioneurotic Oedema, Hypersensitivity, Hypotension, Tachycardia
on Apr 07, 2005 Female patient from FRANCE , 46 years of age, weighting 114.6 lb, was treated with Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, angioneurotic oedema, hypersensitivity, hypotension, tachycardia. Nimbex dosage: 10mg Per Day. During the same period patient was treated with AUGMENTIN '125' (2g Per Day) (View Augmentin '125' Review and Augmentin '125' Label ), CELOCURINE (60mg Per Day) (View Celocurine Review and Celocurine Label ), PERFALGAN (1g Per Day) (View Perfalgan Review and Perfalgan Label ), PROPOFOL (200mg Per Day) (View Propofol Review and Propofol Label ), GELOFUSINE (200ml Per Day) (View Gelofusine Review and Gelofusine Label ), SUFENTA (35mcg Per Day) (View Sufenta Review and Sufenta Label ), BETADINE (View Betadine Review and Betadine Label ).

4748509-5 | Flushing, Hypotension, Infusion Related Reaction
Patient was taking Nimbex (View Usage). Patient had the following side effects: flushing, hypotension, infusion related reaction on Aug 18, 2005 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 216.0 lb, was diagnosed with intubation and. Nimbex dosage: 10mg Once Intravenou. During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), PEPCID (View Pepcid Review and Pepcid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), VERSED (View Versed Review and Versed Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

4714829-3 | Cardiac Arrest, Glasgow Coma Scale Abnormal
Adverse event was reported on Jul 07, 2005 by a Female patient taking Nimbex (View Usage) (Dosage: Not Reported) was diagnosed with analgesic effect and. Location: ITALY , 46 years of age, weighting 198.4 lb, After Nimbex was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), glasgow coma scale abnormal. Patient was hospitalized.

4708538-4 | Bronchospasm, Rash
on Jun 24, 2005 Female patient from FRANCE , 79 years of age, weighting 132.3 lb, was diagnosed with ill-defined disorder and was treated with Nimbex (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, rash (What is rash?). Nimbex dosage: . During the same period patient was treated with ULTIVA (View Ultiva Review and Ultiva Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), ACUPAN (View Acupan Review and Acupan Label ), KETAMINE (View Ketamine Review and Ketamine Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ).

4681060-X | Anaphylactic Reaction, Breath Sounds Decreased, Electrocardiogram St-t Segment Depression, Oxygen Saturation Decreased, Sinus Bradycardia, Sinus Tachycardia
on May 26, 2005 Female patient from , 70 years of age, weighting 110.2 lb, was diagnosed with neuromuscular blockade, induction of anaesthesia, maintenance of anaesthesia and was treated with Nimbex (View Usage). Patient had the following side effects: anaphylactic reaction, breath sounds decreased, electrocardiogram st-t segment depression, oxygen saturation decreased, sinus bradycardia, sinus tachycardia. Nimbex dosage: 8 Mg (0.16 Mg/kg) Rapidly Infused Intravenous Dose. During the same period patient was treated with ASPIRIN (Not Reported) (View Aspirin Review and Aspirin Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ISOFLURANE (Not Reported) (View Isoflurane Review and Isoflurane Label ), NITROUS OXIDE (Not Reported) (View Nitrous Oxide Review and Nitrous Oxide Label ).

4642389-4 | Anaphylactic Shock, Angioneurotic Oedema, Hypotension, Procedural Complication, Tachycardia
Patient was taking Nimbex (View Usage). After Nimbex was administered, patient had the following side effects: anaphylactic shock, angioneurotic oedema, hypotension, procedural complication, tachycardia on Apr 07, 2005 from Additional patient health information: Female patient , 46 years of age, weighting 114.6 lb, was diagnosed with induction of anaesthesia, antibacterial prophylaxis, analgesic effect and. Nimbex dosage: 10mg Per Day. During the same period patient was treated with AUGMENTIN '125' (2g Per Day) (View Augmentin '125' Review and Augmentin '125' Label ), CELOCURINE (60mg Per Day) (View Celocurine Review and Celocurine Label ), PERFALGAN (1g Per Day) (View Perfalgan Review and Perfalgan Label ), PROPOFOL (200mg Per Day) (View Propofol Review and Propofol Label ), GELOFUSINE (200ml Per Day) (View Gelofusine Review and Gelofusine Label ), SUFENTA (35mcg Per Day) (View Sufenta Review and Sufenta Label ), BETADINE (View Betadine Review and Betadine Label ).

4618976-6 | Anaesthetic Complication Neurological, Hypercapnia, Subcutaneous Emphysema, Testicular Swelling
Adverse event was reported on Mar 15, 2005 by a Male patient taking Nimbex (View Usage) (Dosage: ) was diagnosed with hypotonia, anaesthesia, hypertension and. Location: , 68 years of age, Patient experienced the following unwanted or unexpected effects: anaesthetic complication neurological, hypercapnia, subcutaneous emphysema, testicular swelling. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), TOPOROL XL (View Toporol Xl Review and Toporol Xl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).